Cargando…
Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways
Sivelestat sodium (SIV), a neutrophil elastase inhibitor, is mainly used for the clinical treatment of acute respiratory distress syndrome (ARDS) or acute lung injury (ALI). However, studies investigating the effects of SIV treatment of ALI are limited. Therefore, this study investigated the potenti...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171443/ https://www.ncbi.nlm.nih.gov/pubmed/36724020 http://dx.doi.org/10.17305/bb.2022.8549 |
_version_ | 1785039418977943552 |
---|---|
author | Zhang, Hong Zeng, Jun Li, Jiankang Gong, Huankai Chen, Meiling Li, Quan Liu, Shengxing Luo, Shanjun Dong, Huanxiang Xu, Yingke Duan, Huanling Huang, Ling Lv, Chuanzhu |
author_facet | Zhang, Hong Zeng, Jun Li, Jiankang Gong, Huankai Chen, Meiling Li, Quan Liu, Shengxing Luo, Shanjun Dong, Huanxiang Xu, Yingke Duan, Huanling Huang, Ling Lv, Chuanzhu |
author_sort | Zhang, Hong |
collection | PubMed |
description | Sivelestat sodium (SIV), a neutrophil elastase inhibitor, is mainly used for the clinical treatment of acute respiratory distress syndrome (ARDS) or acute lung injury (ALI). However, studies investigating the effects of SIV treatment of ALI are limited. Therefore, this study investigated the potential molecular mechanism of the protective effects of SIV against ALI. Human pulmonary microvascular endothelial cells (HPMECs) were stimulated with tumor necrosis factor α (TNF-α), and male Sprague–Dawley rats were intratracheally injected with Klebsiella pneumoniae (KP) and treated with SIV, ML385, and anisomycin (ANI) to mimic the pathogenetic process of ALI in vitro and in vivo, respectively. The levels of inflammatory cytokines and indicators of oxidative stress were assessed in vitro and in vivo. The wet/dry (W/D) ratio of lung tissues, histopathological changes, inflammatory cells levels in bronchoalveolar lavage fluid (BALF), and survival rates of rats were analyzed. The JNK/NF-κB (p65) and Nrf2/HO-1 levels in the HPMECs and lung tissues were analyzed by western blot and immunofluorescence analyses. Administration of SIV reduced the inflammatory factors levels, intracellular reactive oxygen species (ROS) production, and malondialdehyde (MDA) levels and increased the levels of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in lung tissues. Meanwhile, SIV alleviated pathological injuries, decreased the W/D ratio, and inflammatory cell infiltration in lung tissue. In addition, SIV also inhibited the activation of JNK/NF-κB signaling pathway, promoted nuclear translocation of Nrf2, and upregulated the expression of heme oxygenase 1 (HO-1). However, ANI or ML385 significantly reversed these changes. SIV effectively attenuated the inflammatory response and oxidative stress. Its potential molecular mechanism was related to the JNK/NF-κB activation and Nrf2/HO-1 signaling pathway inhibition. This further deepened the understanding of the protective effects of SIV against ALI. |
format | Online Article Text |
id | pubmed-10171443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina |
record_format | MEDLINE/PubMed |
spelling | pubmed-101714432023-06-01 Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways Zhang, Hong Zeng, Jun Li, Jiankang Gong, Huankai Chen, Meiling Li, Quan Liu, Shengxing Luo, Shanjun Dong, Huanxiang Xu, Yingke Duan, Huanling Huang, Ling Lv, Chuanzhu Biomol Biomed Research Article Sivelestat sodium (SIV), a neutrophil elastase inhibitor, is mainly used for the clinical treatment of acute respiratory distress syndrome (ARDS) or acute lung injury (ALI). However, studies investigating the effects of SIV treatment of ALI are limited. Therefore, this study investigated the potential molecular mechanism of the protective effects of SIV against ALI. Human pulmonary microvascular endothelial cells (HPMECs) were stimulated with tumor necrosis factor α (TNF-α), and male Sprague–Dawley rats were intratracheally injected with Klebsiella pneumoniae (KP) and treated with SIV, ML385, and anisomycin (ANI) to mimic the pathogenetic process of ALI in vitro and in vivo, respectively. The levels of inflammatory cytokines and indicators of oxidative stress were assessed in vitro and in vivo. The wet/dry (W/D) ratio of lung tissues, histopathological changes, inflammatory cells levels in bronchoalveolar lavage fluid (BALF), and survival rates of rats were analyzed. The JNK/NF-κB (p65) and Nrf2/HO-1 levels in the HPMECs and lung tissues were analyzed by western blot and immunofluorescence analyses. Administration of SIV reduced the inflammatory factors levels, intracellular reactive oxygen species (ROS) production, and malondialdehyde (MDA) levels and increased the levels of superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in lung tissues. Meanwhile, SIV alleviated pathological injuries, decreased the W/D ratio, and inflammatory cell infiltration in lung tissue. In addition, SIV also inhibited the activation of JNK/NF-κB signaling pathway, promoted nuclear translocation of Nrf2, and upregulated the expression of heme oxygenase 1 (HO-1). However, ANI or ML385 significantly reversed these changes. SIV effectively attenuated the inflammatory response and oxidative stress. Its potential molecular mechanism was related to the JNK/NF-κB activation and Nrf2/HO-1 signaling pathway inhibition. This further deepened the understanding of the protective effects of SIV against ALI. Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023-06-01 2023-05-01 /pmc/articles/PMC10171443/ /pubmed/36724020 http://dx.doi.org/10.17305/bb.2022.8549 Text en © 2023 Zhang et al. https://creativecommons.org/licenses/by/4.0/This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Research Article Zhang, Hong Zeng, Jun Li, Jiankang Gong, Huankai Chen, Meiling Li, Quan Liu, Shengxing Luo, Shanjun Dong, Huanxiang Xu, Yingke Duan, Huanling Huang, Ling Lv, Chuanzhu Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways |
title | Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways |
title_full | Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways |
title_fullStr | Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways |
title_full_unstemmed | Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways |
title_short | Sivelestat sodium attenuates acute lung injury by inhibiting JNK/NF-κB and activating Nrf2/HO-1 signaling pathways |
title_sort | sivelestat sodium attenuates acute lung injury by inhibiting jnk/nf-κb and activating nrf2/ho-1 signaling pathways |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171443/ https://www.ncbi.nlm.nih.gov/pubmed/36724020 http://dx.doi.org/10.17305/bb.2022.8549 |
work_keys_str_mv | AT zhanghong sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT zengjun sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT lijiankang sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT gonghuankai sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT chenmeiling sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT liquan sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT liushengxing sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT luoshanjun sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT donghuanxiang sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT xuyingke sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT duanhuanling sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT huangling sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways AT lvchuanzhu sivelestatsodiumattenuatesacutelunginjurybyinhibitingjnknfkbandactivatingnrf2ho1signalingpathways |